Trinity Capital Invests $20 Million in Enhancing ABM Respiratory Care's Breathing Solutions

Trinity Capital Invests in ABM Respiratory Care

In a significant move to bolster innovative healthcare solutions, Trinity Capital Inc. announced a $20 million investment in ABM Respiratory Care. This funding is earmarked to support the advancement of groundbreaking breathing therapies that are vital for patients dealing with respiratory conditions.

Based in Phoenix, Arizona, Trinity Capital (NYSE: TRIN) is known for its role as a leading international alternative asset manager, focusing on providing flexible capital to growth-oriented companies. The investment aims to accelerate the commercial expansion of ABM Respiratory Care, a company founded in 2017, which specializes in developing advanced airway clearance and ventilation technologies for diverse clinical settings.

ABM Respiratory Care's Mission

ABM Respiratory Care is dedicated to improving the lives of individuals with acute and chronic respiratory issues. The company's flagship product, the BiWaze® platform, integrates advanced technologies for airway clearance, lung expansion, and secretion management, making it essential for both hospital and home care environments. Moreover, ABM strives to enhance patient engagement through connected care technologies, promoting greater oversight of respiratory therapy utilization.

Quotes from Industry Leaders

Rob Lake, Senior Managing Director of Healthcare and Life Sciences at Trinity Capital, articulated the significance of this collaboration, stating, "For patients with compromised respiratory systems, clearing the lungs and breathing comfortably takes real effort and the right technology. We believe ABM Respiratory Care builds that technology, and we are proud to support the team as they work to bring it to more patients around the world."

Meanwhile, Greg Miller, CEO of ABM Respiratory Care, emphasized the importance of this financing as a milestone in the company's growth and evolution. He remarked, "Building on our current strong commercial momentum, our partnership with Trinity Capital strengthens our financial foundation and provides the capital and operating flexibility to accelerate strategic growth initiatives."

Strategic Growth and Future Innovations

With this new capital infusion, ABM aims to not only solidify its presence in existing markets but also to explore new avenues for growth. The funds will support further product innovation, clinical research, and the expansion of connected respiratory care technologies.

Trinity Capital's dedicated approach to fostering growth in promising companies makes it a valuable partner for ABM as it navigates the complexities of the healthcare market. The move also underscores the growing trend of investments aimed at enhancing patient care through technological advancements in the medical field.

About Trinity Capital Inc.

Founded in 2008, Trinity Capital has deployed over $6.2 billion across more than 490 investments. The firm focuses on private credit markets and offers tailored debt solutions across various sectors, including healthcare, technology, and equipment finance. Their commitment to providing necessary capital reflects a broader strategy to support innovation and growth in a rapidly evolving economic landscape.

About ABM Respiratory Care

ABM Respiratory Care's innovative platform is designed to address respiratory therapy challenges by facilitating deeper breathing and enhancing oxygen exchange while minimizing aerosol exposure. Their commitment to promoting improved disease management is setting new standards in patient care services in and out of healthcare facilities.

In summary, the partnership between Trinity Capital and ABM Respiratory Care signifies a robust commitment to driving innovation in healthcare solutions. This collaboration is poised to significantly impact patient outcomes and propel the adoption of advanced respiratory therapies worldwide.